Search Results - "MADRAS, B. K"

Refine Results
  1. 1

    Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis by Faraone, S V, Spencer, T J, Madras, B K, Zhang-James, Y, Biederman, J

    Published in Molecular psychiatry (01-08-2014)
    “…Much psychiatric genetic research has focused on a 40-base pair variable number of tandem repeats (VNTR) polymorphism located in the 3′-untranslated region…”
    Get full text
    Journal Article
  2. 2

    Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression by MILLER, G. M, MADRAS, B. K

    Published in Molecular psychiatry (2002)
    “…Dopamine transporter (DAT) levels vary in normal subjects and deviate from the normal range in pathological states. We investigated mechanisms by which the DAT…”
    Get full text
    Journal Article
  3. 3

    THC and CBD blood and brain concentrations following daily administration to adolescent primates by Withey, S.L., Bergman, J., Huestis, M.A., George, S.R., Madras, B.K.

    Published in Drug and alcohol dependence (01-08-2020)
    “…•Adolescent primates dosed daily show stable THC, CBD blood levels for 4 months.•Pharmacokinetic tolerance does not develop to THC or CBD.•CBD did not modulate…”
    Get full text
    Journal Article
  4. 4

    Anti-hyperactivity medication : methylphenidate and amphetamine by SEEMAN, P, MADRAS, B. K

    Published in Molecular psychiatry (01-09-1998)
    “…How do 'stimulants' reduce hyperactivity in children and adults? How can drugs which raise extracellular dopamine result in psychomotor slowing of hyperactive…”
    Get full text
    Journal Article
  5. 5

    A mu-opioid receptor single nucleotide polymorphism in rhesus monkey: association with stress response and aggression by MILLER, G. M, BENDOR, J, TIEFENBACHER, S, YANG, H, NOVAK, M. A, MADRAS, B. K

    Published in Molecular psychiatry (01-01-2004)
    “…Variations in the human mu-opioid receptor gene have driven exploration of their biochemical, physiological and pathological relevance. We investigated the…”
    Get full text
    Journal Article
  6. 6

    Dopamine transporter density in patients with attention deficit hyperactivity disorder by DOUGHERTY, D. D, BONAB, A. A, SPENCER, T. J, RAUCH, S. L, MADRAS, B. K, FISCHMAN, A. J

    Published in The Lancet (British edition) (18-12-1999)
    “…Dopamine transporter density was measured in vivo in six adult patients with attention deficit hyperactivity disorder. We have shown a 70% increase in…”
    Get full text
    Journal Article
  7. 7

    Human genetics and pharmacology of neurotransmitter transporters by Lin, Z, Madras, B K

    “…Biogenic amine neurotransmitters are released from nerve terminals and activate pre- and postsynaptic receptors. Released neurotransmitters are sequestered by…”
    Get more information
    Journal Article
  8. 8

    Single nucleotide polymorphisms distinguish multiple dopamine transporter alleles in primates : implications for association with attention deficit hyperactivity disorder and other neuropsychiatric disorders by MILLER, G. M, DE LA GARZA, R. II, NOVAK, M. A, MADRAS, B. K

    Published in Molecular psychiatry (2001)
    “…The human dopamine transporter (DAT) gene contains a variable number tandem repeat (VNTR; 40 bases/3 to >11 repeats) in the 3'-untranslated region (3'-UTR),…”
    Get full text
    Journal Article
  9. 9

    2-Carbomethoxy-3-aryl-8-bicyclo[3.2.1]octanes:  Potent Non-Nitrogen Inhibitors of Monoamine Transporters by Meltzer, Peter C, Blundell, Paul, Yong, Yaw F, Chen, Zhengming, George, Clifford, Gonzalez, Mario D, Madras, Bertha K

    Published in Journal of medicinal chemistry (10-08-2000)
    “…Cocaine is a potent central nervous system stimulant with severe addiction liability. Its reinforcing and stimulant properties derive from inhibition of…”
    Get full text
    Journal Article
  10. 10

    Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys by Bergman, J, Madras, B K, Johnson, S E, Spealman, R D

    “…The self-administration of cocaine was compared with that of bupropion, 1-(2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine, mazindol,…”
    Get more information
    Journal Article
  11. 11

    Cannabinoid receptor agonist and antagonist effects on motor function in normal and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-treated non-human primates by MESCHLER, Justin P, HOWLETT, Allyn C, MADRAS, Bertha K

    Published in Psychopharmacologia (01-06-2001)
    “…Although cannabinoid effects on motor function have been extensively studied in rodents, the role of cannabinoids in regulating behavior in primates is…”
    Get full text
    Journal Article
  12. 12

    Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes by Spealman, R D, Bergman, J, Madras, B K, Melia, K F

    “…The involvement of dopamine (DA) receptor subtypes in the discriminative stimulus effects of cocaine was investigated in squirrel monkeys trained to…”
    Get more information
    Journal Article
  13. 13

    Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane by Madras, B K, Spealman, R D, Fahey, M A, Neumeyer, J L, Saha, J K, Milius, R A

    Published in Molecular pharmacology (01-10-1989)
    “…The potent cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)-tropane (CFT, also designated WIN 35,428) was tritiated and evaluated as a molecular…”
    Get more information
    Journal Article
  14. 14

    1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues:  A Promising Class of Monoamine Uptake Inhibitors by Meltzer, Peter C, Butler, David, Deschamps, Jeffrey R, Madras, Bertha K

    Published in Journal of medicinal chemistry (23-02-2006)
    “…Dopamine, serotonin, and norepinephrine are essential for neurotransmission in the mammalian system. These three neurotransmitters have been the focus of…”
    Get full text
    Journal Article
  15. 15

    Substituted 3-phenyltropane analogs of cocaine: synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging by Meltzer, P. C, Liang, A. Y, Brownell, A. L, Elmaleh, D. R, Madras, B. K

    Published in Journal of medicinal chemistry (02-04-1993)
    “…It is now accepted that (-)-cocaine binds to specific recognition sites associated with monoamine transporters in the mammalian brain. In this study, several…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder by Madras, Bertha K., Miller, Gregory M., Fischman, Alan J.

    Published in Biological psychiatry (1969) (01-06-2005)
    “…The high incidence of attention-deficit/hyperactivity disorder (ADHD) and escalating use of ADHD medications present a compelling case for clarifying the…”
    Get full text
    Journal Article Conference Proceeding
  18. 18

    Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen by Madras, B K, Fahey, M A, Bergman, J, Canfield, D R, Spealman, R D

    “…Specific binding sites for [3H]cocaine were identified in caudate-putamen membranes prepared from nonhuman primate brains (Macaca fascicularis and Saimiri…”
    Get more information
    Journal Article
  19. 19

    Polymorphisms in the 3[variant prime]-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression by Miller, G M, Madras, B K

    Published in Molecular psychiatry (01-01-2002)
    “…Dopamine transporter (DAT) levels vary in normal subjects and deviate from the normal range in pathological states. We investigated mechanisms by which the DAT…”
    Get full text
    Journal Article
  20. 20

    Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on schedule-controlled behavior by Spealman, R D, Madras, B K, Bergman, J

    “…The behavioral effects of cocaine were compared with those of several cocaine derivatives and structurally distinct drugs that inhibit monoamine uptake…”
    Get more information
    Journal Article